Geron Announces Opening of IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis,

Geron Corporation, a late-stage clinical biopharmaceutical company, today announced the opening for patient screening and enrollment of the IMpactMF Phase 3 clinical trial of imetelstat, a …, Geron Corporation, a late-stage clinical biopharmaceutical company, today announced the opening for patient screening and enrollment of the IMpactMF Phase 3 clinical trial of imetelstat, a …, Read More

Scroll to Top